NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Datavault AI Inc. (NASDAQ: DVLT) between September 4, 2024 and October 30, 2025, inclusive (the “Class Period”), of the important October 5, 2026 lead plaintiff deadline. SO WHAT: If you purchased Datavault AI […]

NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Aardvark Therapeutics, Inc. (NASDAQ: AARD): (i) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with Aardvark’s February 13, 2025 initial public offering (“IPO”); and/or […]

NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) between March 9, 2026 and June 24, 2026, inclusive (the “Class Period”), of the important October 5, 2026 lead plaintiff deadline. SO WHAT: If you purchased ARS […]